Regulation of hematopoietic stem cell maintenance and survival by NKAP

NKAP 对造血干细胞维持和存活的调节

基本信息

  • 批准号:
    9040250
  • 负责人:
  • 金额:
    $ 39.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-01 至 2017-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We have found that a transcriptional repressor first defined functionally in our laboratory, NKAP, is absolutely required for the maintenance of the hematopoietic stem cell (HSC) pool. Steady state hematopoiesis is sustained through differentiation balanced with proliferation and self-renewal of HSCs. Disruption of this balance can lead to hematopoietic failure, as in the case of hematopoietic differentiation without self-renewal which leads to the loss of the HSC pool. An understanding of the molecular regulation of HSC maintenance could lead to therapeutic interventions to hasten HSC reconstitution, for example, in bone marrow transplants. In adult mice, inducible deletion of NKAP results in hematopoietic failure and rapid lethality. NKAP deletion results in a complete, cell-intrinsic loss of all HSCs, through a combination of decreased survival and decreased proliferation. Therefore, NKAP is critical for HSC maintenance and survival. To understand the molecular basis for the requirement of NKAP in HSCs, we performed a yeast two hybrid screen, and identified that NKAP associates with the polycomb repressive complex-1 (PRC1) E3 ubiquitin ligase Ring1b. PRC1 is recruited to sites of H3K27 trimethylation, an inhibitory epigenetic mark, leading to monoubiquitination of H2AK119. Mutations in three components of PRC1, Ring1b, Bmi-1, and Rae28, disrupt HSC function, indicating the importance of this pathway for maintaining the HSC pool. In ex vivo short term HSC cultures, loss of NKAP leads to a global and severe downregulation of H2AK119 monoubiquitation, indicating that NKAP is a critical regulator of PRC1 in HSCs. This proposal will focus on elucidating the mechanism of Ring1b/PRC1 regulation by NKAP, and to uncover the molecular basis for the contribution of NKAP to HSC maintenance and survival. Specific Aim 1: Defining the mechanism of regulation of Ring1b/PRC1 function by NKAP Specific Aim 2: Identification of genes downstream of NKAP that are required for HSC maintenance and survival Specific Aim 3: Defining the critical pathways regulated by NKAP in HSCs through identification of the protein-protein domains and associations required for NKAP-mediated regulation of HSC maintenance and survival.
描述(由申请人提供):我们发现一种转录抑制因子NKAP在我们的实验室中首次被功能性地定义,对于维持造血干细胞(HSC)池是绝对必需的。稳态造血是通过造血干细胞的增殖和自我更新平衡的分化来维持的。这种平衡的破坏可导致造血功能衰竭,如在造血分化没有自我更新的情况下,导致HSC池的损失。对HSC维持的分子调控的理解可能导致加速HSC重建的治疗干预,例如在骨髓移植中。在成年小鼠中,诱导缺失NKAP会导致造血功能衰竭和快速死亡。NKAP的缺失导致细胞内在的完全丧失

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Virginia Smith Shapiro其他文献

Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP.
激活的 T 细胞和 AP-1 的核因子不足以激活 IL-2 启动子:RE/AP 上调 CD28 的必要条件。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Virginia Smith Shapiro;M. Mollenauer;Arthur Weiss
  • 通讯作者:
    Arthur Weiss
The nutrient-sensing Rag-GTPase complex in B cells controls humoral immunity via TFEB/TFE3-dependent mitochondrial fitness
B 细胞中的营养感应 Rag-GTP 酶复合物通过依赖 TFEB/TFE3 的线粒体适应性来控制体液免疫
  • DOI:
    10.1038/s41467-024-54344-5
  • 发表时间:
    2024-11-23
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Xingxing Zhu;Yue Wu;Yanfeng Li;Xian Zhou;Jens O. Watzlawik;Yin Maggie Chen;Ariel L. Raybuck;Daniel D. Billadeau;Virginia Smith Shapiro;Wolfdieter Springer;Jie Sun;Mark R. Boothby;Hu Zeng
  • 通讯作者:
    Hu Zeng

Virginia Smith Shapiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Virginia Smith Shapiro', 18)}}的其他基金

Altered TCR signaling in anergy
无能状态下 TCR 信号传导的改变
  • 批准号:
    10750486
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
Training Program in Immunology
免疫学培训计划
  • 批准号:
    10493678
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
Training Program in Immunology
免疫学培训计划
  • 批准号:
    10650170
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
Regulation of B cell development by ABCB7
ABCB7 对 B 细胞发育的调节
  • 批准号:
    10374116
  • 财政年份:
    2021
  • 资助金额:
    $ 39.75万
  • 项目类别:
Regulation of gene expression by HDAC3
HDAC3 对基因表达的调节
  • 批准号:
    10455700
  • 财政年份:
    2020
  • 资助金额:
    $ 39.75万
  • 项目类别:
Regulation of gene expression by HDAC3
HDAC3 对基因表达的调节
  • 批准号:
    10225415
  • 财政年份:
    2020
  • 资助金额:
    $ 39.75万
  • 项目类别:
Regulation of gene expression by HDAC3
HDAC3 对基因表达的调节
  • 批准号:
    10667604
  • 财政年份:
    2020
  • 资助金额:
    $ 39.75万
  • 项目类别:
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
  • 批准号:
    10308083
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
  • 批准号:
    10529298
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:
ST8Sia6 expression on tumors inhibits the immune response
肿瘤上 ST8Sia6 的表达抑制免疫反应
  • 批准号:
    9913027
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:

相似海外基金

Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
  • 批准号:
    10722602
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
  • 批准号:
    10368246
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells
Eltombopag:对正常和再生障碍性贫血造血干细胞的新作用模式
  • 批准号:
    10676888
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
  • 批准号:
    10600143
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
The effects of somatic HLA class I allele mutations on antigen presentation in acquired aplastic anemia
体细胞 HLA I 类等位基因突变对获得性再生障碍性贫血抗原呈递的影响
  • 批准号:
    10347646
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
  • 批准号:
    10370775
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
The effects of somatic HLA class I allele mutations on antigen presentation in acquired aplastic anemia
体细胞 HLA I 类等位基因突变对获得性再生障碍性贫血抗原呈递的影响
  • 批准号:
    10545024
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
Identification of autoantigens presented by specific HLA class I alleles in aplastic anemia
再生障碍性贫血中特定 HLA I 类等位基因呈现的自身抗原的鉴定
  • 批准号:
    19H03686
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of novel genes related to aplastic anemia using mouse models.
使用小鼠模型对与再生障碍性贫血相关的新基因进行功能分析。
  • 批准号:
    19K08297
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了